Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
McKesson
Cantor Fitzgerald
Baxter
AstraZeneca
Boehringer Ingelheim
McKinsey
Fish and Richardson
Dow
Chubb

Generated: August 17, 2017

DrugPatentWatch Database Preview

SALUTENSIN Drug Profile

« Back to Dashboard

What is the patent landscape for Salutensin, and when can generic versions of Salutensin launch?

Salutensin is a drug marketed by Shire and is included in one NDA.

The generic ingredient in SALUTENSIN is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.

Summary for Tradename: SALUTENSIN

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list71
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SALUTENSIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire
SALUTENSIN
hydroflumethiazide; reserpine
TABLET;ORAL012359-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Shire
SALUTENSIN-DEMI
hydroflumethiazide; reserpine
TABLET;ORAL012359-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Boehringer Ingelheim
Medtronic
Dow
Covington
AstraZeneca
Johnson and Johnson
Teva
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot